Location History:
- Grosse Pointe Farms, MI (US) (1993)
- Grosse Point Farms, MI (US) (1997)
Company Filing History:
2 out of 75 
1 out of 3,381 
Years Active: 1993-1997
Title: Joseph D Shore: Innovator in Thrombolysis and Plasminogen Research
Introduction
Joseph D Shore is a notable inventor based in Grosse Pointe Farms, MI (US). He has made significant contributions to the field of medical research, particularly in thrombolysis and plasminogen studies. With a total of 2 patents, his work has the potential to impact therapeutic approaches in clot management.
Latest Patents
Joseph D Shore's latest patents include innovative methods and compositions aimed at enhancing thrombolysis. One of his inventions, titled "Peptide mediated enhancement of thrombolysis methods and compositions," focuses on peptides that decrease the half-life of active plasminogen activator inhibitor-1. This invention provides methods and compositions for utilizing these peptides to improve clot lysis. Another significant patent is "Active site labelling of plasminogen," which involves a plasminogen that incorporates a label into its active site, rendering it enzymatically inactive upon conversion to plasmin. This patent also includes an assay method utilizing the labelled plasminogen.
Career Highlights
Throughout his career, Joseph D Shore has worked with esteemed organizations such as Henry Ford Health System and the University of Michigan. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Steven T Olson and Daniel Lawrence. Their collaborative efforts have further advanced the research and development of innovative medical solutions.
Conclusion
Joseph D Shore's contributions to thrombolysis and plasminogen research highlight his role as an influential inventor in the medical field. His patents reflect a commitment to improving therapeutic methods for clot management.